SOURCE: Premiere Publishing Group, Inc.

November 30, 2010 09:48 ET

Premiere Publishing Group, Inc. Signs Letter of Intent With Xi'an Johnson Pharmaceutical Ltd.

TOTOWA, NJ--(Marketwire - November 30, 2010) - Premiere Publishing Group, Inc. (OTCQB: PPBL) (OTCBB: PPBL) is pleased to announce the signing of a Letter of Intent with Xi'an Johnson Pharmaceutcial Ltd.

Xi'an Johnson Pharmaceutical Ltd. is a company based in Mainland China in the business of wholesale and retail distribution of both pharmaceuticals and herbal medicines.

Premiere's Chief Executive Officer Mr. Omar Barrientos stated, "We are excited by the prospects to finalize a business combination between Xi'an Johnson Pharmaceutical, Ltd. with a wholly owned subsidiary of Premiere Publishing Group, Inc. We are in the process of finalizing our due diligence efforts and anticipate a closing in the first quarter 2011. This is just the beginning of our ongoing strategy to create long term shareholder value thru the expertise and assistance we can provide private companies globally. We are aggressively seeking out highly profitable companies such as Xi'an Johnson Pharmaceutical, Ltd. to close business combinations with in order to substantiate Premiere Publishing Group, Inc. as a public company with shareholder value creation as its main focus.

"We are currently in negotiations with several other highly profitable companies and expect to conclude those negotiations in the not too distant future. We have developed substantial relationships overseas and expect to manifest the value of those relationships throughout 2011 and beyond. 

"In addition, as part of our overall strategy we will also be changing the name of the company in the new year to better reflect the type of company we are positioning ourselves as and expect to report back to our shareholders as it relates to our other areas of progress as well."

Contact Information